MedTrace Logo

Sirolimus- and Paclitaxel-Eluting Stents for Small Vessels (ISAR-SMART-3)

NCT00146575 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2008-01-11

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy of paclitaxel- and sirolimus-eluting stents to prevent re-blockage of small coronary arteries

Conditions

  • Coronary Disease

Interventions

DEVICE

Sirolimus-eluting stent (Cypher)

patients have been implanted a Cypher stent

DEVICE

Paclitaxel-eluting stent (Taxus)

patients have been implanted a Taxus stent

Sponsors & Collaborators

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Principal Investigators

  • Albert Schomig, MD · Deutsches Herzzentrum Muenchen

  • Adnan Kastrati, MD · Deutsches Herzzentrum Muenchen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-06-30
Completion
2005-02-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00146575 on ClinicalTrials.gov